Calciotropic Hormones and Bone Markers in the Elderly
- 1 March 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 13 (3), 475-482
- https://doi.org/10.1359/jbmr.1998.13.3.475
Abstract
There is a lack of substantial data on changes in calciotropic hormones and bone markers in elderly subjects living in North America. Parathyroid hormone (PTH), serum 25-hydroxyvitamin D (25(OH)D) and bone markers (serum osteocalcin and urine N-telopeptide), were measured in 735 Caucasian subjects (235 men and 500 women) aged 65-87 years. There was a significant increase in serum osteocalcin and urine N-telopeptide with age in men, and a significant increase in serum osteocalcin with age in women. Serum PTH and 25(OH)D showed no significant change with age in men or women. After adjusting for age, calcium intake, serum creatinine, season, and weight, mean serum PTH (p = 0.01), serum osteocalcin (p = 0.0001) and 24 h urine N-telopeptide (p = 0.0001) were higher in women than men, and mean serum 25(OH)D (p = 0.0001) and 24 h urine calcium (p = 0.0001) were higher in men than women. Serum PTH was correlated with serum osteocalcin in men and women, r = 0.24, r = 0.17, p < 0.001, but not with urine N-telopeptide. Serum PTH was inversely correlated with serum 25(OH)D (r = -0.25, r = -034,p < 0.001), and positively correlated with serum creatinine (r = 0.14, r = 0.17,p < 0.01) in men and women. The prevalence of serum 25(OH)D levels below 12 ng/ml was only 33% in females and 0.4% in men. Thus vitamin D deficiency was very uncommon in the U.S.A. compared with Europe. Although mean serum PTH was increased in the elderly, only 4-6% had PTH levels above the normal range. In summary, the increase in serum PTH in the elderly can be explained more by changes in vitamin D status than by declining renal function. These data also show significantly higher (p = 0.001) bone remodeling markers in women.Keywords
This publication has 38 references indexed in Scilit:
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal womenJournal of Bone and Mineral Research, 1996
- Effect of Vitamin D Intake on Seasonal Variations in Parathyroid Hormone Secretion in Postmenopausal WomenNew England Journal of Medicine, 1989
- Total bone calcium in normal women: Effect of age and menopause statusJournal of Bone and Mineral Research, 1987
- Age-related rise in parathyroid hormone in man: The use of intact and midmoleeule antisera to distinguish hormone secretion from retentionJournal of Bone and Mineral Research, 1987
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Relative Contributions of Aging and Estrogen Deficiency to Postmenopausal Bone LossNew England Journal of Medicine, 1984
- Serum 1,25-Dihydroxyvitamin D in Normal Subjects and in Patients with Postmenopausal Osteopenia. Influence of Age, Renal Function and Oestrogen TherapyHormone and Metabolic Research, 1982
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJCI Insight, 1979
- Intestinal Absorption of 45Ca in Senile OsteoporosisActa Medica Scandinavica, 1963